Evolution of viral life-cycle in response to cytotoxic T lymphocyte-mediated immunity

Journal of Theoretical Biology

Volumn 310, Issue , 2012, Pages 3-13

  Louzoun, Yoram ^a   Ganusov, Vitaly V ^b  

^a BAR ILAN UNIVERSITY   (Israel)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Dynamics; Epitopes; Evolution; Immunology; ODE

Indexed keywords

EPITOPE; VIRUS PROTEIN;

GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; LIFE CYCLE; MUTATION; PROTEIN; VIRUS;

AMINO ACID SEQUENCE; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; LIFE CYCLE; MOLECULAR EVOLUTION; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSMISSION;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; COMPUTER SIMULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; MICE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC; VIRUS DISEASES; VIRUSES;

MAMMALIA; MUS;

EID: 84863489486     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.06.020     Document Type: Article

References (82)

1. Almani M., Raffaeli S., Vider-Shalit T., Tsaban L., Fishbain V., Louzoun Y. Human self-protein CD8+ T-cell epitopes are both positively and negatively selected. Eur. J. Immunol. 2009, 39:1056-1065.
2. Agranovich A., Vider-Shalit T., Louzoun Y. Optimal viral immune surveillance evasion strategies. Theor. Popul. Biol. 2011, 80:233-243.
3. Antia R., Ganusov V.V., Ahmed R. The role of models in understanding CD8+ T-cell memory. Nat. Rev. Immunol. 2005, 5:101-111.
4. Althaus C.L., Ganusov V.V., De Boer R.J. Dynamics of CD8+ T cell responses during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 2007, 179:2944-2951.
5. Antia R., Levin B.R., May R.M. Within-host population-dynamics and the evolution and maintenance of microparasite virulence. Am. Nat. 1994, 144:457-472.
6. Braciale T.J., Braciale V.L. Antigen presentation: structural themes and functional variations. Immunol. Today 1991, 12:124-129.
7. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B.A. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 1997, 3:205-211.
8. Boutwell C.L., Rowley C.F., Essex M. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J. Virol. 2009, 83:2460.
9. Borghans J.A., Beltman J.B., De Boer R.J. MHC polymorphism under host-pathogen coevolution. Immunogenetics 2004, 55:732-739.
10. Beauchemin C., Handel A. A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead. BMC Public Health 2011, 11:S7.
11. Bonhoeffer S., Funk G.A., Gunthard H.F., Fischer M., Muller V. Glancing behind virus load variation in HIV-1 infection. Trends Microbiol. 2003, 11:499-504.
12. Baccam P., Beauchemin C., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J. Virol. 2006, 80:7590-7599.
13. Budhu S., Loike J.D., Pandolfi A., Han S., Catalano G., Constantinescu A., Clynes R., Silverstein S.C. CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues. J. Exp. Med. 2010, 207:223-235.
14. Coombs D., Gilchrist M.A., Ball C.L. Evaluating the importance of within- and between-host selection pressures on the evolution of chronic pathogens. Theor. Popul. Biol. 2007, 72:576-591.
15. Coombs D., Gilchrist M.A., Percus J., Perelson A.S. Optimal viral production. Bull. Math. Biol. 2003, 65:1003-1023.
16. Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 2004, 199:905.
17. Dahari H., Layden-Almer J.E., Kallwitz E., Ribeiro R.M., Cotler S.J., Layden T.J., Perelson A.S. A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease. Gastroenterology 2009, 136:1402-1409.
18. De Boer R.J., Oprea M., Antia R., Murali-Krishna K., Ahmed R., Perelson A.S. Recruitment times, proliferation, and apoptosis rates during the CD8(+) T-cell response to lymphocytic choriomeningitis virus. J. Virol. 2001, 75:10663-10669.
19. De Boer R.J., Homann D., Perelson A.S. Different dynamics of CD4+ and CD8+ T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol. 2003, 171:3928-3935.
20. Davenport M.P., Ribeiro R.M., Perelson A.S. Kinetics of virus-specific CD8+ T cells and the control of human immunodeficiency virus infection. J. Virol. 2004, 78:10096-10103.
21. De Boer R.J., Ribeiro R.M., Perelson A.S., Fraser C. Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLoS Comput. 2010.
22. Fields B.N., Knipe D.M., Howley P.M., Griffin D.E. Fields Virology 2001, Lippincott Williams & Wilkins, Philadelphia, xix, 3087 pp.
23. Fields B.N., Knipe D.M., Howley P.M. Fields' virology 2007, Lippincott Williams & Wilkins, Philadelphia, 2 v. (xix, 3091, I-86) pp.
24. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4:25-36.
25. Goulder P.J.R., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AID. Nat. Med. 1997, 3:212-217.
26. Ginodi I., Vider-Shalit T., Tsaban L., Louzoun Y. Precise score for the prediction of peptides cleaved by the proteasome. Bioinformatics 2008, 24:477-483.
27. Goonetilleke N., Liu M.K., Salazar-Gonzalez J.F., Ferrari G., Giorgi E., Ganusov V.V., Keele B.F., Learn G.H., Turnbull E.L., Salazar M.G., Weinhold K.J., Moore S., Letvin N., Haynes B.F., Cohen M.S., Hraber P., Bhattacharya T., Borrow P., Perelson A.S., Hahn B.H., Shaw G.M., Korber B.T., McMichael A.J. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 2009, 206:1253-1272.
28. Goulder P.J., Klenerman P. Cytotoxic T lymphocytes and viral adaptation in HIV infection. Curr. Opin. HIV AIDS 2006, 1:241-248.
29. Gilchrist M.A., Coombs D. Evolution of virulence: interdependence, constraints, and selection using nested models. Theor. Popul. Biol. 2006, 69:145-153.
30. Gilchrist M.A., Coombs D., Perelson A.S. Optimizing within-host viral fitness: infected cell lifespan and virion production rate. J. Theor. Biol. 2004, 229:281-288.
31. Ganusov V.V., Barber D.L., De Boer R.J. Killing of targets by CD8+ T cells in the mouse spleen follows the law of mass action. PLoS One 2011, 6:e15959.
32. Ganusov V.V., Lukacher A.E., Byers A.M. Persistence of viral infection despite similar killing efficacy of antiviral CD8(+) T cells during acute and chronic phases of infection. Virology 2010, 405:193-200.
33. Ganusov V.V. Discriminating between different pathways of memory CD8+ T cell differentiation. J. Immunol. 2007, 179:5006-5013.
34. Ganusov V.V., Bergstrom C.T., Antia R. Within-host population dynamics and the evolution of microparasites in a heterogeneous host population. Evolution 2002, 56:213-223.
35. Ganusov V.V., Antia R. Trade-offs and the evolution of virulence of microparasites: do details matter?. Theor. Popul. Biol. 2003, 64:211-220.
36. Gilchrist M.A., Sasaki A. Modeling host-parasite coevolution: a nested approach based on mechanistic models. J. Theor. Biol. 2002, 218:289-308.
37. Gras S., Kedzierski L., Valkenburg S.A., Laurie K., Liu Y.C., Denholm J.T., Richards M.J., Rimmelzwaan G.F., Kelso A., Doherty P.C. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl. Acad. Sc. 2010, 107:12599.
38. Hellerstein M., Hanley M., Cesar D., Siler S., Papageorgopoulos C., Wieder E., Schmidt D., Hoh R., Neese R., Macallan D. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 1999, 5:83-89.
39. Handel A., Longini I.M., Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comput. Biol. 2007, 3:e240.
40. Hershberg U., Louzoun Y., Atlan H., Solomon S. HIV time hierarchy: winning the war while, loosing all the battles. Physica A: Stat. Mech. Appl. 2001, 289:178-190.
41. http://bimas.cit.nih.gov/.
42. Kagi D., Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 1996, 8:472-477.
43. Kagi D., Ledermann B., Burki K., Zinkernagel R.M., Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 1996, 14:207-232.
44. Kleijmeer M.J., Kelly A., Geuze H.J., Slot J.W., Townsend A., Trowsdale J. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 1992, 357:342-344.
45. Kotturi M.F., Peters B., Buendia-Laysa F., Sidney J., Oseroff C., Botten J., Grey H., Buchmeier M.J., Sette A. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 2007, 81:4928-4940.
46. Kovjazin R., Volovitz I., Daon Y., Vider-Shalit T., Azran R., Tsaban L., Carmon L., Louzoun Y. Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: implications for vaccine development. Mol. Immunol. 2011, 48:1009-1018.
47. Leslie A., Kavanagh D., Honeyborne I., Pfafferott K., Edwards C., Pillay T., Hilton L., Thobakgale C., Ramduth D., Draenert R. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J. Exp. Med. 2005, 201:891-902.
48. Leslie A., Pfafferott K., Chetty P., Draenert R., Addo M., Feeney M., Tang Y., Holmes E., Allen T., Prado J. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004, 10:282-289.
49. Louzoun Y., Vider T., Weigert M. T-cell epitope repertoire as predicted from human and viral genomes. Mol. Immunol. 2006, 43:559-569.
50. Merbl Y., Itzchak R., Vider-Shalit T., Louzoun Y., Quintana F.J., Vadai E., Eisenbach L., Cohen I.R. A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice. PLoS One 2009, 4:e6053.
51. Maman Y., Blancher A., Benichou J., Yablonka A., Efroni S., Louzoun Y. Immune-induced evolutionary selection focused on a single reading frame in overlapping hepatitis B virus proteins. J. Virol. 2011, 85:4558-4566.
52. McMichael A.J., Borrow P., Tomaras G.D., Goonetilleke N., Haynes B.F. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 2010, 10:11-23.
53. Miao H., Hollenbaugh J.A., Zand M.S., Holden-Wiltse J., Mosmann T.R., Perelson A.S., Wu H., Topham D.J. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus. J. Virol. 2010, 84:6687-6698.
54. Mellors J.W., Kingsley L.A., Rinaldo C.R., Todd J.A., Hoo B.S., Kokka R.P., Gupta P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 1995, 122:573-579.
55. Murphy K.P., Travers P., Walport M., Janeway C. Janeway's Immunobiology 2008, Garland Science, New York, xxi, 887 pp.
56. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., Perelson A.S. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998, 282:103-107.
57. Obar J.J., Khanna K.M., Lefrancois L. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity 2008, 28:859-869.
58. Phillips R.E., Rowland-Jones S., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., Elvin J.G., Rothbard J.A., Bangham C., Rizza C.R. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354:453.
59. Price D.A., Goulder P.J.R., Klenerman P., Sewell A.K., Easterbrook P.J., Troop M., Bangham C.R.M., Phillips R.E. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. 1997, 94:1890.
60. Payne R.P., Matthews P.C., Prado J.G., Goulder P.J. HLA-mediated control of HIV and HIV adaptation to HLA. Adv. Parasitol. 2009, 68:1-20.
61. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
62. Purbhoo M.A., Irvine D.J., Huppa J.B., Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 2004, 5:524-530.
63. Rock K.L., York I.A., Saric T., Goldberg A.L. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 2002, 80:1-70.
64. Ramratnam B., Bonhoeffer S., Binley J., Hurley A., Zhang L., Mittler J.E., Markowitz M., Moore J.P., Perelson A.S., Ho D.D. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 1999, 354:1782-1785.
65. Ribeiro R.M., Qin L., Chavez L.L., Li D., Self S.G., Perelson A.S. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J. Virol. 2010, 84:6096-6102.
66. Regoes R.R., Barber D.L., Ahmed R., Antia R. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1599-1603.
67. Sebzda E., Mariathasan S., Ohteki T., Jones R., Bachmann M.F., Ohashi P.S. Selection of the T cell repertoire. Annu. Rev. Immunol. 1999, 17:829-874.
68. Sanchez-Merino V., Farrow M.A., Brewster F., Somasundaran M., Luzuriaga K. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness. J. Infect. Dis. 2008, 197:300.
69. Smith S.M. HIV CTL escape: at what cost?. Retrovirology 2004, 1:8.
70. Sun K., Ye J., Perez D.R., Metzger D.W. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J. Immunol. 2011, 186:987.
71. Townsend A., Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 1989, 7:601-624.
72. Tu W., Mao H., Zheng J., Liu Y., Chiu S.S., Qin G., Chan P.L., Lam K.T., Guan J., Zhang L. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 2010, 84:6527.
73. van den Broek M.F., Hengartner H. The role of perforin in infections and tumour surveillance. Exp. Physiol. 2000, 85:681-685.
74. Vider-Shalit T., Fishbain V., Raffaeli S., Louzoun Y. Phase-dependent immune evasion of herpesviruses. J. Virol. 2007, 81:9536-9545.
75. Vider-Shalit T., Almani M., Sarid R., Louzoun Y. The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire. AIDS 2009, 23:1311-1318.
76. Vider-Shalit T., Sarid R., Maman K., Tsaban L., Levi R., Louzoun Y. Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis. Bioinformatics 2009, 25:i39-i44.
77. Vider-Shalit T., Louzoun Y. MHC-I prediction using a combination of T cell epitopes and MHC-I binding peptides. J. Immunol. Methods 2010.
78. Wodarz D., Nowak M.A. Mathematical models of HIV pathogenesis and treatment. BioEssays 2002, 24:1178-1187.
79. Yang O.O., Kalams S.A., Trocha A., Cao H., Luster A., Johnson R.P., Walker B.D. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 1997, 71:3120.
80. Yewdell J.W. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 2006, 25:533-543.
81. Yates A., Graw F., Barber D.L., Ahmed R., Regoes R.R., Antia R. Revisiting estimates of CTL killing rates in vivo. PLoS One 2007, 2:e1301.
82. Yates A.J., Van Baalen M., Antia R. Virus replication strategies and the critical CTL numbers required for the control of infection. PLoS Comput. Biol. 2011, 7:e1002274.